CF PHARMTECH, INC. - H SHARES
(HKEX: 2652)

CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. The company focuses on complex products and platforms, innovative medicines, and medical devices. It also offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. The company was founded by Liang Wenqing and Li Li in 2007 and is headquartered in Suzhou, China.

35.280 -

-0.300 (-0.84%)
价格区间 34.480 - 35.980   (4.35%)
开盘 35.980
昨收 35.580
35.280
买盘 ('000) 7
35.640
卖盘 ('000) 0.5
成交量 ('000) 167
成交额 5,857,860
注释 -
数据延迟。最后一次更新12 Feb 2026 16:08.
数据提供商
查看所有活动

Loading Chart...

Please login to view stock data and analysis